NHS pilots rapid genomic test to transform brain tumour diagnosis and treatment, experts say
The nanopore test identifies tumour type in about two hours, helping patients start treatment sooner and reach clinical trials faster, NHS England said.
- NHS England launched a pioneering rapid genomic test that slashes brain tumour diagnosis times from up to eight weeks to two hours, enabling faster treatment and clinical trial access.
- Brain tumours remain "notoriously difficult" to identify, with over 100 distinct forms existing; more than 12,000 people in the UK are diagnosed annually, facing weeks of agonizing uncertainty.
- Using shoebox-sized Oxford Nanopore sequencers, clinicians analyze tumour samples in 20 minutes; Neurosurgeon Stuart Smith at Nottingham University Hospitals NHS Trust recently used this method to diagnose patient Steve Palmer during surgery.
- Prof Frankie Swords, NHS medical director, said the test "has the potential to completely transform" diagnosis and care, enabling faster access to tailored treatments and clinical trials.
- The pilot involves five specialist centres in Nottingham, Birmingham, London, and Newcastle, with expansion plans to Bristol, Oxford, Leeds, and Manchester, ensuring consistent national access.
35 Articles
35 Articles
Rare tumor tomography in the brain. Ely Venancio/EPTV A new test can help identify brain tumors much faster and speed up a definitive diagnosis, something essential for successful treatment. The technology, which was developed by the Brain Tumor Research Center of the University of Nottingham, UK, is already being tested at the UK National Health Service (NHS). The exam quickly analyzes the DNA, or genetic code, of a small sample of the tumor re…
The British National Health Service (NHS) is conducting tests with this rapid diagnostic system, able to analyze the genetic characteristics of a tumor and determine more precisely what type it is.
Develops scientists and doctors at Nottingham University and Nottingham University Hospitals of the British Health Services Authority,
NHS England is to launch a pilot programme to make a rapid genetic test available to brain tumour patients, with experts saying the new method could revolutionise diagnosis and treatment, Sky News reported.
An advanced test for brain tumors has been developed in the UK that will significantly shorten diagnosis time.
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
